Search Results - "Storey, RF"
-
1
-
2
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Published in The New England journal of medicine (18-04-2019)“…The prevention of stroke and restenosis of coronary arteries in patients with atrial fibrillation who have an acute coronary syndrome or undergo percutaneous…”
Get full text
Journal Article -
3
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Published in European heart journal (14-01-2016)Get full text
Journal Article Web Resource -
4
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Published in European journal of cardio-thoracic surgery (01-01-2018)Get full text
Journal Article -
5
-
6
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis
Published in European heart journal (21-01-2023)“…The first international guidance on antithrombotic therapy in the elderly came from the European Society of Cardiology Working Group on Thrombosis in 2015…”
Get full text
Journal Article -
7
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function: Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Published in Circulation (New York, N.Y.) (14-09-2010)“…Reduced renal function is associated with a poorer prognosis and increased bleeding risk in patients with acute coronary syndromes and may therefore alter the…”
Get full text
Journal Article -
8
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Published in Atherosclerosis (01-07-2011)Get full text
Journal Article Web Resource -
9
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
Published in European heart journal (01-06-2013)Get full text
Journal Article -
10
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis
Published in European heart journal (22-08-2023)“…Abstract Patients with severe infections and a pre-existing indication for antithrombotic therapy, i.e. antiplatelet agents, anticoagulant drugs, or their…”
Get full text
Journal Article Conference Proceeding -
11
Antiplatelet agents for the treatment and prevention of atherothrombosis
Published in European heart journal (01-12-2011)“…The clinical pharmacology of antiplatelet drugs has been reviewed previously by the European Society of Cardiology (ESC) Task force and by the 8th American…”
Get full text
Journal Article -
12
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis
Published in European heart journal (07-06-2017)Get full text
Journal Article -
13
Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial
Published in European journal of preventive cardiology (01-06-2015)“…Aims To determine the effect of ticagrelor compared to clopidogrel in patients with peripheral artery disease (PAD) and acute coronary syndromes (ACS). Methods…”
Get full text
Journal Article -
14
Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction
Published in Thrombosis and haemostasis (04-07-2016)“…Delays in the onset of action of prasugrel during primary percutaneous coronary intervention (PPCI) have been reported and could be related to the effects of…”
Get more information
Journal Article -
15
Kinetics and Mechanism of the Stannous Octoate-Catalyzed Bulk Polymerization of ε-Caprolactone
Published in Macromolecules (26-02-2002)“…Bulk polymerizations of ε-caprolactone (CL) were conducted at 130 °C, in which the structure and amount of initiator were varied. Polymerization induction…”
Get full text
Journal Article -
16
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Published in European heart journal. Cardiovascular pharmacotherapy (15-03-2021)“…abstract Timely and effective antithrombotic therapy is critical to improving outcome, including survival, in patients with acute coronary syndrome (ACS)…”
Get full text
Journal Article -
17
Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi‐country observational study
Published in Clinical cardiology (Mahwah, N.J.) (01-10-2021)“…Introduction Clinical guidelines recommend extended treatment with dual antiplatelet therapy (DAPT) with ticagrelor 60 mg (twice daily) beyond 12 months in…”
Get full text
Journal Article -
18
Aspirin resistance and diabetes mellitus
Published in Diabetologia (01-03-2008)Get full text
Journal Article -
19
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study
Published in Thrombosis and haemostasis (2017)“…Dyspnoea may be induced by some reversibly-binding P2Y inhibitors, including cangrelor and ticagrelor. Dyspnoea was not associated with any compromise to the…”
Get more information
Journal Article -
20
DAPA-MI - A Registry-Based Randomized Trial of Dapagliflozin in Patients With Acute Myocardial Infarction Without Diabetes
Published in CIRCULATION (2023)Get full text
Conference Proceeding